Lees Pharmaceutical Holdings Ltd 2020 SR
The report details Lee's Pharmaceutical Holdings Limited's environmental, social, and governance performance for the 2020 fiscal year. It highlights a substantial decrease in Scope 1 greenhouse gas emissions and an overall reduction in total GHG emissions intensity compared to the previous year. The company emphasizes its adherence to the HKEX ESG Reporting Guide, focusing on resource efficiency, waste management, and employee welfare. Key social efforts included maintaining a safe workplace and supporting education through charitable donations. The report also covers the group's stringent supply chain management and product responsibility standards within the pharmaceutical industry.
Company: Lees Pharmaceutical Holdings Ltd
Sector: Health Care
Country: Hong Kong
Year: 2020
Type: SR
Pages: 10
Lees Pharmaceutical Holdings Ltd
The report details Lee's Pharmaceutical Holdings Limited's environmental, social, and governance performance for the 2020 fiscal year. It highlights a substantial decrease in Scope 1 greenhouse gas emissions and an overall reduction in total GHG emissions intensity compared to the previous year. The company emphasizes its adherence to the HKEX ESG Reporting Guide, focusing on resource efficiency, waste management, and employee welfare. Key social efforts included maintaining a safe workplace and supporting education through charitable donations. The report also covers the group's stringent supply chain management and product responsibility standards within the pharmaceutical industry.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Apr 21, 2021
Type
Sustainability Report
Language
English, Chinese
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Employees